Dtt. Chua et al., The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma, CANCER, 92(11), 2001, pp. 2845-2855
BACKGROUND. A retrospective analysis of treatment outcomes in patients with
nasopharyngeal carcinoma (NPC) was performed in which the newly revised 19
97 American Joint Committee on Cancer (AJCC) stage classification was appli
ed and compared with the 1988 AJCC and Ho stage classifications, with empha
sis on the predictive value of different staging systems in determining fai
lure patterns in NPC.
METHODS. Three hundred and twenty-four patients with newly diagnosed NPC tr
eated between September 1989 and August 1991 and originally staged accordin
g to Ho stage classification were re-staged according to the 1988 and 1997
AJCC stage classifications. In addition to stage grouping, patients were al
so classified into the following prognostic categories to study the failure
patterns: early disease group (T1-2N0-1), advanced local disease group (T3
-4N0-1), advanced nodal disease group (T1-2N2-3), and advanced locoregional
disease group (T3-4N2-3). The overall survival (OAS), relapse-free surviva
l (RFS), local relapse-free survival, nodal relapse-free survival, and dist
ant metastases-free survival were compared among different stage groups and
prognostic categories in the three staging systems.
RESULTS. In the new AJCC system, the percentages of patients with Stage I,
II, III, and IV disease were 15.1%, 31.5%, 28.1%, and 25.3%, respectively,
whereas most patients were classified as having Stage IV disease (65.7%) in
the old AJCC system and Stage II or III disease (74.1%) in the Ho system.
The 5 year OAS rates in the 1997 AJCC Stage I, II, III, and IV disease were
97.7%, 78.7%, 79.5%, and 61.4%, respectively. The corresponding 5 year RFS
rates were 95.7%, 64.7%, 54.5%, and 41.1%. Using the 1997 AJCC system to d
efine the four prognostic categories, the early disease group had the lowes
t incidence of relapse (27.6%) and death (18.4%), whereas the advanced loco
regional disease group had the highest incidence of relapse (61.4%) and dea
th (43.2%). Both the advanced local disease group and the advanced nodal di
sease group had similar rates of relapse (46.7% vs. 47.2%), but local relap
se was the major cause of failure in the former group (61.8%), whereas dist
ant metastases was the major cause in the latter group (44%).
CONCLUSIONS. Using the 1997 AJCC staging system, the authors observed a bet
ter distribution of patient numbers as well as segregation of survival curv
es among different stage groups. Moreover, prognostic categories with disti
nct prognosis and failure patterns were definable by the new system, which
has important implications in selecting appropriate patient treatment strat
egies. Cancer 2001;92: 2845-55. (C) 2001 American Cancer Society.